Specificity of pCAR T cell activation is dependent upon binding to the CAR target antigen (in this case, αvβ6 integrin, which is tumor selective), while signaling is boosted upon engagement of ErbB dimers, which are less tumor selective. The gene discussed is EGFR; the disease is neoplasm.